ORAGENICS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
ORAGENICS, INC. (OGEN) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$101.23 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2016-05-16
- ORAGENICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-12-31 was $0.00.
- ORAGENICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-09-30 was -$7.34K.
- ORAGENICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-06-30 was -$21.65K, a 5206.60% decline year-over-year.
- ORAGENICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-03-31 was -$72.24K.
- ORAGENICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$101.23K.
- ORAGENICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$110.25K.
- ORAGENICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$18.81K.
- ORAGENICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2012 was -$11.10K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$7.34K derived: sum of 2 quarters · filed 2016-03-30 | -$28.99K derived: sum of 3 quarters · filed 2016-03-30 | -$101.23K 10-K · filed 2016-03-30 |
| 2015-09-30 | -$7.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$28.99K derived: sum of 2 quarters · filed 2015-11-06 | -$101.23K 10-Q · filed 2015-11-06 | -$191.78K derived: sum of 4 quarters · filed 2016-05-16 |
| 2015-06-30 | -$21.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$93.89K 10-Q · filed 2015-08-07 | -$184.43K derived: sum of 3 quarters · filed 2016-05-16 | -$185.67K derived: sum of 4 quarters · filed 2016-05-16 |
| 2015-03-31 | -$72.24K 10-Q · filed 2016-05-16 | -$162.78K derived: sum of 2 quarters · filed 2016-05-16 | -$164.02K derived: sum of 3 quarters · filed 2016-05-16 | -$163.60K derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | -$90.54K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$91.78K derived: sum of 2 quarters · filed 2016-03-30 | -$91.36K derived: sum of 3 quarters · filed 2016-03-30 | -$110.25K 10-K · filed 2016-03-30 |
| 2014-09-30 | -$1.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$816.00 derived: sum of 2 quarters · filed 2015-11-06 | -$19.70K 10-Q · filed 2015-11-06 | -$20.86K derived: sum of 4 quarters · filed 2015-11-06 |
| 2014-06-30 | $424.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$18.46K 10-Q · filed 2015-08-07 | -$19.63K derived: sum of 3 quarters · filed 2015-08-07 | -$30.90K derived: sum of 4 quarters · filed 2015-08-07 |
| 2014-03-31 | -$18.89K 10-Q · filed 2015-05-08 | -$20.05K derived: sum of 2 quarters · filed 2015-05-08 | -$31.32K derived: sum of 3 quarters · filed 2015-05-08 | |
| 2013-12-31 | -$1.16K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$12.44K derived: sum of 2 quarters · filed 2015-02-27 | -$18.81K 10-K · filed 2015-02-27 | |
| 2013-09-30 | -$11.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | -$17.65K 10-Q · filed 2014-11-03 | ||
| 2013-06-30 | -$6.37K 10-Q · filed 2014-08-07 | |||
| 2012-12-31 | -$11.10K 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |